University Of California, Los Angeles
Clinical trials sponsored by University Of California, Los Angeles, explained in plain language.
-
Can a buddy system help people with HIV and addiction stay in care?
Disease control Not yet recruitingThis study tests a peer navigation program for 250 people living with HIV who also use substances. The program assigns a trained peer to help participants stay connected to HIV care and substance use services. Researchers will measure viral suppression and clinic attendance to se…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can screening for social needs improve diabetes care for kids?
Disease control Not yet recruitingThis study tests a program where social workers screen families of youth with type 1 diabetes for social challenges like food insecurity, then connect them to community resources. The goal is to see if this approach is practical and acceptable, and whether it can improve diabetes…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New trial aims to stop stomach bleeding before it starts
Disease control Not yet recruitingThis study tests whether treating enlarged stomach veins (gastric varices) early with a procedure called retrograde transvenous obliteration (RTO) can prevent dangerous bleeding. 68 adults with cirrhosis and gastric varices will be randomly assigned to either RTO or standard care…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can lifestyle coaching and therapy protect autistic teens from heart disease?
Disease control Not yet recruitingThis study tests two approaches—lifestyle medicine consultations and cognitive behavioral therapy (CBT)—to reduce cardiovascular risk in autistic individuals aged 9 to 26 who have a high body mass index. Participants are randomly assigned to receive lifestyle coaching, CBT sessio…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New Super-Food could help malnourished kids recover faster and smarter
Disease control Not yet recruitingThis study tests a new, energy-rich therapeutic food for children aged 6 to 59 months with severe acute malnutrition. Researchers want to see if it helps kids recover physically and improves their brain development compared to the standard food. About 125 children in Pakistan wil…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Baking soda for kidney stones? new study tests cheaper alternative
Disease control Not yet recruitingThis study compares a cheap medicine, sodium bicarbonate, to the standard prescription potassium citrate for preventing kidney stones. About 30 adults with a history of stones and low urinary citrate will take one of the two medicines. The goal is to see if sodium bicarbonate can…
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a simple salt solution help the brain after severe injury?
Disease control Not yet recruitingThis study tests whether a sodium lactate infusion is safe for people with severe traumatic brain injury in the ICU. Researchers will monitor side effects and survival in 264 adults. The goal is to see if this approach is safe enough to study further.
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
THCV: a new weapon against smoking?
Symptom relief Not yet recruitingThis study tests whether a compound from cannabis called THCV can help people who smoke daily to resist cigarettes and smoke less. 32 smokers will receive either THCV or a placebo and then take a test measuring how long they can delay smoking and how many cigarettes they smoke. T…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New drug aims to cut opioid use after common knee surgery
Symptom relief Not yet recruitingThis study tests whether a new painkiller called suzetrigine can help people use fewer opioids after ACL surgery while still controlling pain. About 140 participants will receive either suzetrigine or standard opioid-based pain care and report their pain, opioid use, and side eff…
Phase: PHASE4 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
A simple tool may help thyroid cancer patients avoid treatment regret
Symptom relief Not yet recruitingMany people with small thyroid cancers can choose between a less extensive surgery (lobectomy) or a more extensive one (total thyroidectomy), yet some pick the riskier option without clear reason. This study tests whether an electronic decision navigation tool — one that highligh…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
UCLA study: magnesium pills may boost athlete sleep and performance
Symptom relief Not yet recruitingThis study looks at whether taking magnesium glycinate or magnesium L-threonate at night can improve sleep, recovery, and athletic performance in UCLA varsity athletes. 150 participants will take either a magnesium supplement or a placebo for 4 weeks. Sleep and recovery data will…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New drug could replace opioids for Post-Surgery pain
Symptom relief Not yet recruitingThis study tests whether suzetrigine, a new painkiller that works on nerves without affecting the brain, can control pain after pelvic surgery as well as standard opioids. 120 women will receive either suzetrigine or opioids, along with common pain relievers. The goal is to see i…
Phase: PHASE4 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Magic mushroom therapy for depression? new trial tests psilocybin and CBT in groups
Symptom relief Not yet recruitingThis phase 2 trial will test whether giving psilocybin (the active ingredient in magic mushrooms) along with group cognitive behavioral therapy is acceptable and feasible for people with major depression. Thirty adults with current depressive symptoms will receive two doses of ps…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Magnetic brain zaps aim to ease anorexia in youth
Symptom relief Not yet recruitingThis early study tests whether a non-invasive brain stimulation technique called rTMS can help reduce symptoms of anorexia nervosa in 45 people aged 14 to 24. Participants will receive 20 daily sessions of rTMS, which uses magnets to stimulate the brain. Researchers will track ch…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a seizure pill boost memory in Alzheimer's? UCLA launches new trial
Symptom relief Not yet recruitingThis early-phase study tests whether brivaracetam, a seizure medication, can calm overactive brain areas and improve thinking in 25 adults aged 45–70 with mild Alzheimer's or mild cognitive impairment. Participants will have brain activity monitored via scalp and depth electrodes…
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Predicting kidney trouble in older adults: a data-driven approach to clearer lab results
Knowledge-focused Not yet recruitingResearchers are refining a computer model that estimates the risk of chronic kidney disease progression in adults over 65. Using existing health records from 18,000 patients, the study aims to make the model more accurate and easier for doctors to explain. No new treatments are b…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Can a pill mimic cannabis? new study tests oral THC and CBD
Knowledge-focused Not yet recruitingThis study will give 22 occasional cannabis users oral THC, CBD, both, or a placebo to measure how these substances appear in blood and saliva, and how they affect thinking and behavior. The goal is to better understand drug detection and impairment from oral cannabinoids. It is …
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
New imaging method could improve pelvic pain treatment
Knowledge-focused Not yet recruitingThis study aims to better understand and treat myofascial pelvic pain, a common cause of long-term pelvic pain in women. Researchers will use a noninvasive imaging technique to measure pelvic floor muscle function before and after three different treatments: education with relaxa…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can digital therapy break the cycle of worry and rumination?
Knowledge-focused Not yet recruitingThis study will enroll 500 adults with high levels of repetitive negative thinking (like worry or rumination) to understand why cognitive-behavioral therapy helps. Participants will receive one of two digital therapy programs: one focusing on concrete thinking, the other on self-…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Scientists to inflame Drinkers' bodies to uncover craving triggers
Knowledge-focused Not yet recruitingThis study aims to understand how inflammation in the body influences mood and alcohol cravings in people with alcohol use disorder (AUD). Researchers will give 64 participants (32 with AUD and 32 without) a single low dose of a substance that causes temporary inflammation or a p…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC